48 Ken Fisher Revvity Trades
Ken Fisher's position in Revvity is currently worth $6.6 Million. That's 0.00% of their equity portfolio (450th largest holding). The first Revvity trade was made in Q1 2013. Since then Ken Fisher bought shares nineteen more times and sold shares on 28 occasions. The stake costed the investor $2.23 Million, netting the investor a gain of 196% so far.
News about Revvity Inc. and Ken Fisher
Cell Image Analysis System Market Marvelous Growth 2026 | Growing Internationally profiling by: GE Healthcare, Nikon Corporation, BD, PerkinElmer, Merck, Thermo Fisher Scientific
A recently introduced Global Cell Image Analysis System Market report includes factors such as size, growth, share, industry trends and project its growth by...
North America Biotechnology Market Report 2027: Top Key Players Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, PerkinElmer Inc
Businessmarketinsights Latest update on North America Biotechnology Market Analysis, North America Biotechnology market growth analysis and Projection by 20...
Multiplex Biomarker Imaging Market 2021-2028 | Latest COVID19 Impact Analysis | Know About Brand Players: Thermo Fisher, US Biomax, PerkinElmer, Merck, Cisbio, Roche
Global Multiplex Biomarker Imaging Market Synopsis: To accomplish highest return on investment (ROI), its very essential to know about market parameters such...
Automated DNA Extraction Systems Market Research with complete Industry Segmentation and Key Trends 2021 2028| Thermo Fisher Scientific, Qiagen, PerkinElmer, LGC, Promega, Kurabo Biomedical
The Global Automated DNA Extraction Systems Market report presents a comprehensive summary, market shares and growth opportunities of the Automated DNA Extra...